ES8603497A1 - Procedimiento para preparar derivados de cefalosporina - Google Patents

Procedimiento para preparar derivados de cefalosporina

Info

Publication number
ES8603497A1
ES8603497A1 ES536550A ES536550A ES8603497A1 ES 8603497 A1 ES8603497 A1 ES 8603497A1 ES 536550 A ES536550 A ES 536550A ES 536550 A ES536550 A ES 536550A ES 8603497 A1 ES8603497 A1 ES 8603497A1
Authority
ES
Spain
Prior art keywords
derivatives
preparation
cephalasporin
pharmaceutical preparations
bacterial infections
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES536550A
Other languages
English (en)
Other versions
ES536550A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of ES536550A0 publication Critical patent/ES536550A0/es
Publication of ES8603497A1 publication Critical patent/ES8603497A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/48Methylene radicals, substituted by hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE DERIVADOS DE CEFALOSPORINA Y DE SUS SALES DE ADICION DE ACIDOS FISIOLOGICAMENTE COMPATIBLES, DE FORMULA (I), EN LA QUE R1 REPRESENTA HIDROGENO O METOXI; Y A, Z Y R2 PUEDEN SER VARIOS TIPOS DE RADICALES. CONSISTE EN LA REACCION DE UN COMPUESTO DE FORMULA (II), EN LA QUE R1, R2 Y Z TIENEN EL MISMO SIGNIFICADO QUE EN LA FORMULA (I), Y R6 REPRESENTA UN GRUPO INTERCAMBIABLE POR UNA DE LAS BASES CORRESPONDIENTES AL RADICAL A DE LA FORMULA (I), CON ESTA BASE. LA REACCION SE EFECTUA EN UN DISOLVENTE INERTE, EN PRESENCIA DE TRIMETILYODOSILANO, A UNA TEMPERATURA COMPRENDIDA ENTRE 60JC Y 120JC. TAMBIEN SE PUEDE PARTIR DE UN COMPUESTO DE FORMULA (III), EN LA QUE R7 REPRESENTA HIDROGENO O UN GRUPO PROTECTOR DE AMINO. ESTOS COMPUESTOS TIENEN APLICACIONES FARMACOLOGICAS PARA EL TRATAMIENTO DE INFECCIONES MICROBIANAS.-
ES536550A 1983-10-08 1984-10-05 Procedimiento para preparar derivados de cefalosporina Expired ES8603497A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3336756 1983-10-08
DE19843409431 DE3409431A1 (de) 1983-10-08 1984-03-15 Cephalosporinderivate und verfahren zu ihrer herstellung

Publications (2)

Publication Number Publication Date
ES536550A0 ES536550A0 (es) 1985-12-16
ES8603497A1 true ES8603497A1 (es) 1985-12-16

Family

ID=25814731

Family Applications (1)

Application Number Title Priority Date Filing Date
ES536550A Expired ES8603497A1 (es) 1983-10-08 1984-10-05 Procedimiento para preparar derivados de cefalosporina

Country Status (13)

Country Link
EP (1) EP0137440A3 (es)
KR (1) KR850002991A (es)
AU (1) AU3388384A (es)
DE (1) DE3409431A1 (es)
DK (1) DK479684A (es)
ES (1) ES8603497A1 (es)
FI (1) FI843933L (es)
GR (1) GR80574B (es)
HU (1) HU190878B (es)
IL (1) IL73190A0 (es)
MA (1) MA20250A1 (es)
NO (1) NO844006L (es)
PT (1) PT79317B (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60231683A (ja) * 1984-05-02 1985-11-18 Teijin Ltd セフアロスポリン誘導体その製造法及びそれを有効成分とする抗菌剤
DE3419013A1 (de) * 1984-05-22 1985-11-28 Bayer Ag, 5090 Leverkusen Neue cephalosporine und verfahren zu ihrer herstellung
EP0452987B1 (en) * 1984-12-27 1995-03-01 Banyu Pharmaceutical Co., Ltd. Isoindoline derivatives
IL77458A (en) * 1985-01-14 1990-07-26 Eisai Co Ltd Cephem derivatives,their production and antibacterial compositions containing them and certain novel intermediates therefor
US4698336A (en) * 1985-01-30 1987-10-06 Eisai Co., Ltd. 3-(pyrrolidinio)methyl-3-cephem derivatives
DE3506159A1 (de) * 1985-02-22 1986-08-28 Bayer Ag, 5090 Leverkusen Neue cephalosporine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
EP0237735B1 (en) * 1986-03-17 1994-03-30 Fujisawa Pharmaceutical Co., Ltd. 3,7-Disubstituted-3-cephem compounds and process for production of the same
US4814328A (en) * 1986-03-19 1989-03-21 Banyu Pharmaceutical Co., Ltd. Cephalosporin derivatives, and antibacterial agents
AT388919B (de) * 1987-04-01 1989-09-25 Biochemie Gmbh Verfahren zur herstellung von cephalosporinderivaten
US4929612A (en) * 1987-04-17 1990-05-29 Eisai Co., Ltd. Thiadiazolylacetamide cephem derivatives
US5336768A (en) * 1988-05-24 1994-08-09 Hoffmann-La Roche Inc. Antibacterial cephalosporin compounds
HUT49889A (en) * 1988-03-31 1989-11-28 Hoffmann La Roche Process for producing acyl derivatives
TW526202B (en) 1998-11-27 2003-04-01 Shionogi & Amp Co Broad spectrum cephem having benzo[4,5-b]pyridium methyl group of antibiotic activity
US7847093B2 (en) 2003-04-16 2010-12-07 Sandoz Ag Processes for the preparations of cefepime
ES2348299T3 (es) * 2003-04-16 2010-12-02 Sandoz Ag Procedimientos para la preparación de cefepime.
WO2007096740A2 (en) * 2006-02-20 2007-08-30 Orchid Research Laboratories Limited Novel cephalosporins
US9320740B2 (en) 2013-03-15 2016-04-26 Merck Sharp & Dohme Corp. Ceftolozane-tazobactam pharmaceutical compositions
MX2020004205A (es) 2013-03-15 2021-11-16 Merck Sharp & Dohme Llc Composiciones antibioticas de ceftolozano.
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
AU2014233637A1 (en) 2013-09-09 2015-03-26 Merck Sharp & Dohme Corp. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US8906898B1 (en) 2013-09-27 2014-12-09 Calixa Therapeutics, Inc. Solid forms of ceftolozane

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1131618A (en) * 1978-10-27 1982-09-14 Cynthia H. O'callaghan Cephalosporin compounds
GR78245B (es) * 1980-09-12 1984-09-26 Ciba Geigy Ag
CA1213882A (en) * 1982-03-04 1986-11-12 Jun Okumura Cephalosporins
US4457929A (en) * 1982-03-29 1984-07-03 Bristol-Myers Company 3-Quaternary ammonium methyl)-substituted cephalosporin derivatives
US4525473A (en) * 1983-03-30 1985-06-25 Bristol-Myers Company Cephalosporins

Also Published As

Publication number Publication date
EP0137440A3 (de) 1986-01-08
IL73190A0 (en) 1985-01-31
PT79317B (de) 1986-10-20
MA20250A1 (fr) 1985-07-01
DK479684D0 (da) 1984-10-05
DK479684A (da) 1985-04-09
HU190878B (en) 1986-11-28
ES536550A0 (es) 1985-12-16
FI843933L (fi) 1985-04-09
NO844006L (no) 1985-04-09
FI843933A0 (fi) 1984-10-05
AU3388384A (en) 1985-04-18
DE3409431A1 (de) 1985-04-18
HUT37152A (en) 1985-11-28
KR850002991A (ko) 1985-05-28
PT79317A (de) 1984-11-01
GR80574B (en) 1985-02-01
EP0137440A2 (de) 1985-04-17

Similar Documents

Publication Publication Date Title
ES8304143A1 (es) "procedimiento para la preparacion de derivados de cefem".
ES8603497A1 (es) Procedimiento para preparar derivados de cefalosporina
AU565927B2 (en) Cephalosporin derivatives
AU555444B2 (en) Cephalosporin derivatives
ZA891162B (en) Cephalosporin derivatives and processes for their preparation
IE880503L (en) Crystallized cephem-acid addition salts, and a process for the preparation thereof
ES2002903A6 (es) Procedimiento para preparar derivados de cefalosporina
CA2013226A1 (en) Cephalosporin derivatives and processes for their preparation